Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,784.00
-10.60 (-0.59%)
Apr 21, 2026, 3:20 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 295.67 billion as of April 21, 2026. Its market cap has increased by 10.57% in one year.
Market Cap
295.67B
Enterprise Value
266.68B
Revenue
61.13B
Ranking
n/a
PE Ratio
34.90
Stock Price
1,784.00
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 295.67B, a decrease of -0.48%. That is a compound annual growth rate of -0.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 295.67B | 4.22% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 634.81B |
| Laurus Labs | 613.14B |
| Ipca Laboratories | 372.51B |
| Ajanta Pharma | 348.46B |
| Emcure Pharmaceuticals | 317.01B |
| Wockhardt | 228.06B |
| NATCO Pharma | 200.55B |
| Eris Lifesciences | 198.45B |